Clinical Trial Update: A Phase III Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus. [Phase 3]

View source ↗

Summary

A Phase III trial of MR13A9 in hemodialysis patients with uremic pruritus has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uremic Pruritus

Drugs mentioned

• MR13A9

Snippet

Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Uremic Pruritus | Phase 3 | Status: COMPLETED | Results posted: 2025-09-10